WO2014027612A1 - Bone repair material and production method therefor - Google Patents

Bone repair material and production method therefor Download PDF

Info

Publication number
WO2014027612A1
WO2014027612A1 PCT/JP2013/071596 JP2013071596W WO2014027612A1 WO 2014027612 A1 WO2014027612 A1 WO 2014027612A1 JP 2013071596 W JP2013071596 W JP 2013071596W WO 2014027612 A1 WO2014027612 A1 WO 2014027612A1
Authority
WO
WIPO (PCT)
Prior art keywords
ions
aqueous solution
bone
acid
calcium
Prior art date
Application number
PCT/JP2013/071596
Other languages
French (fr)
Japanese (ja)
Inventor
小久保 正
松下 富春
シーカー ナス
山口 誠二
Original Assignee
学校法人中部大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 学校法人中部大学 filed Critical 学校法人中部大学
Priority to JP2014530537A priority Critical patent/JP6206880B2/en
Publication of WO2014027612A1 publication Critical patent/WO2014027612A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)

Abstract

[Problem] To provide a highly safe bone repair material that gradually releases bone-forming ions and that exhibits excellent apatite-forming ability and storability. [Solution] The production method of the present invention is characterized by comprising: a step in which a substrate comprising titanium or a titanium alloy is immersed in an alkaline first aqueous solution that contains cations of sodium ions and/or potassium ions and that does not contain calcium ions or bone-forming ions; a step in which the substrate is immersed in a second solution that contains calcium ions and at least one kind of bone-forming ions selected from among strontium ions, magnesium ions, zinc ions, lithium ions, and gallium ions; a step in which the substrate is heated in a dry atmosphere; and a step in which the substrate is immersed in a third aqueous solution containing at least one of water, an acidic aqueous solution, and/or an aqueous solution containing bone-forming ions.

Description

骨修復材料及びその製造方法Bone repair material and manufacturing method thereof
 この発明は、骨修復材料及びその製造方法に関する。この骨修復材料は、大腿骨、股関節、脊椎、歯根等のように大きな荷重の加わる部分における骨修復のために好適に利用され得る。 The present invention relates to a bone repair material and a manufacturing method thereof. This bone repair material can be suitably used for bone repair in a portion to which a large load is applied such as a femur, a hip joint, a spine, and a tooth root.
 表面にアパタイト層を有するチタン金属またはチタン合金は、大きな破壊靱性を有し、且つ生体内でアパタイトを介して生体骨と結合することから、大きな荷重の加わる部分における骨修復材料として期待され、チタン金属またはチタン合金からなる基材の表面にアパタイト層を形成する方法が種々検討されてきた。このうち、アルカリ処理された基材をアパタイトの飽和濃度以上の水溶液に浸けてアパタイトを析出させて得られるものは、乾燥時にアパタイトにひび割れを生じやすい。また、基材にアパタイトをプラズマ溶射あるいは火炎溶射により被覆する方法で得られるものは、冷却時に基材との熱膨張差によりアパタイト層に亀裂を生じやすい。このため、体内でアパタイトを形成させ、これを介して生体骨と結合させるべく、アパタイト形成能を有するチタン酸塩層を表面に形成させるチタン金属またはチタン合金の化学処理法が種々提案されている(特許文献1-3)。 Titanium metal or titanium alloy having an apatite layer on the surface has great fracture toughness and is bonded to living bone through apatite in vivo, so it is expected as a bone repair material in a portion where a large load is applied. Various methods for forming an apatite layer on the surface of a substrate made of a metal or a titanium alloy have been studied. Among these, what is obtained by immersing an alkali-treated base material in an aqueous solution having a saturated concentration of apatite or more to precipitate apatite tends to crack the apatite during drying. Moreover, what is obtained by the method of coat | covering an apatite by a plasma spraying or flame spraying to a base material tends to produce a crack in an apatite layer by the thermal expansion difference with a base material at the time of cooling. For this reason, various chemical treatment methods for titanium metal or titanium alloy have been proposed in which apatite is formed in the body, and a titanate layer having an apatite-forming ability is formed on the surface in order to form apatite through the body and bond with living bone. (Patent Documents 1-3).
 一方、ストロンチウム、マグネシウム、亜鉛、リチウム、ガリウムなどのイオンは、体内で新たな生体骨の形成を促進すると報告されている(特許文献4-5、非特許文献1-6)。骨修復材料周囲に早期に生体骨が形成され、しかも材料表面に早期にアパタイト層が形成されれば、骨修復材料と生体骨との間に早期に強い結合が得られると期待される。また、骨粗鬆症などで骨量の減少した患者においても骨量の回復が期待される。 On the other hand, ions such as strontium, magnesium, zinc, lithium and gallium are reported to promote the formation of new living bones in the body (Patent Documents 4-5 and Non-Patent Documents 1-6). If a living bone is formed around the bone repair material at an early stage and an apatite layer is formed on the material surface at an early stage, it is expected that a strong bond will be obtained between the bone repair material and the living bone at an early stage. In addition, recovery of bone mass is expected even in patients whose bone mass has decreased due to osteoporosis or the like.
WO95/13100号公報WO95 / 13100 publication WO2009/147819号公報WO2009 / 147819 WO2010/087427号公報WO2010 / 087427 特表2010-533012Special table 2010-533012 特表2010-533011Special table 2010-533011
 しかし、特許文献1に記載された工程のみで得られる材料は、長期保存を想定した加速試験として高温多湿下に骨修復材料を長期間曝すと、アパタイト形成能を失ってしまう。したがって、修復手術に備えて在庫品を保存しておくことができない。
 特許文献2及び3に記載された工程のみで得られる材料は、アパタイト形成能及び保存性に優れているが、骨形成を促進する能力に乏しい。
 特許文献4-5及び非特許文献1-2に記載の方法で得られる材料はストロンチウム、亜鉛またはリチウムのイオンを溶出して骨形成を促進するが、そのアパタイト形成能は低い。
 それ故、この発明の課題は、骨形成イオンを徐放し、且つアパタイト形成能及び保存性に優れた安全性の高い骨修復材料を提供することにある。
However, the material obtained only by the process described in Patent Document 1 loses the ability to form apatite when the bone repair material is exposed to high temperature and humidity for a long period of time as an accelerated test assuming long-term storage. Therefore, it is not possible to store inventory in preparation for repair surgery.
The materials obtained only by the processes described in Patent Documents 2 and 3 are excellent in apatite forming ability and storage stability, but are poor in ability to promote bone formation.
The materials obtained by the methods described in Patent Document 4-5 and Non-Patent Document 1-2 promote the bone formation by eluting ions of strontium, zinc or lithium, but their apatite forming ability is low.
Therefore, an object of the present invention is to provide a highly safe bone repair material that releases bone-forming ions gradually and is excellent in apatite-forming ability and storage stability.
 その課題を解決するために、この発明の骨修復材料は、
 チタン金属またはチタン合金からなる基材と、その基材表面にあってカルシウムイオン及び骨形成イオンを含むチタン酸塩層とを備え、10mN以上のひっかき抵抗を有することを特徴とする。この明細書において、ひっかき抵抗とは、バネ定数200g/mmのスタイラスに前記チタン酸塩層上で100μmの振幅を与え、100mN/minの荷重を印加しながら、スタイラスを10μm/secの速度で移動させたとき、前記チタン酸塩層が有する臨界ひっかき強度をいう。
In order to solve the problem, the bone repair material of the present invention is
It comprises a substrate made of titanium metal or a titanium alloy and a titanate layer containing calcium ions and osteogenic ions on the surface of the substrate, and has a scratch resistance of 10 mN or more. In this specification, the scratch resistance means that a stylus having a spring constant of 200 g / mm is given an amplitude of 100 μm on the titanate layer, and a stylus is moved at a speed of 10 μm / sec while applying a load of 100 mN / min. The critical scratch strength of the titanate layer when it is applied.
 この骨修復材料によれば、チタン酸塩層がカルシウムイオン及び骨形成イオンの両方を含むので、チタン酸塩層に含まれる骨形成イオンが生体内で徐々に溶出して周囲の骨形成を促進し、同時にカルシウムイオンが生体内で溶出してアパタイト形成能を示して骨と結合することを可能にする。前記ひっかき抵抗は、それ自体が直接示す機械的特性だけでなく、アパタイト形成能及び骨形成イオンの徐放性を示す指標でもある。即ち、ひっかき抵抗が10mNに満たないほどに、チタン酸塩層内の粒子間結合が弱いと、骨形成イオンが急速に溶出してしまい、骨形成を促進させるのに効果的でない。同様にカルシウムイオンも急速に溶出してしまい、アパタイトの核形成と成長を促進する効果を示さない。 According to this bone repair material, since the titanate layer contains both calcium ions and bone forming ions, the bone forming ions contained in the titanate layer gradually elute in vivo to promote the surrounding bone formation. At the same time, calcium ions are eluted in the living body, exhibiting the ability to form apatite, and can bind to bone. The scratch resistance is not only a mechanical property directly shown by itself, but also an index showing apatite forming ability and sustained release of bone forming ions. That is, if the interparticle bond in the titanate layer is so weak that the scratch resistance is less than 10 mN, the bone-forming ions are rapidly eluted, which is not effective in promoting bone formation. Similarly, calcium ions are also eluted rapidly and do not show the effect of promoting apatite nucleation and growth.
 この発明の骨修復材料を製造する方法は、カルシウムイオン及び骨形成イオンを含まずナトリウムイオン及びカリウムイオンのうち1つ以上の陽イオンを含むアルカリ性の第1の水溶液に、チタンまたはチタン合金からなる基材を浸漬する工程と、カルシウムイオン及び骨形成イオンを含む第2の水溶液に基材を浸漬する工程と、基材を大気中で加熱する工程と、水、酸水溶液及び骨形成イオン含有水溶液から選ばれる一種以上からなる第3の水溶液に浸漬する工程を備えることを特徴とする。 The method for producing a bone repair material of the present invention comprises titanium or a titanium alloy in an alkaline first aqueous solution that does not contain calcium ions and bone forming ions but contains at least one cation of sodium ions and potassium ions. A step of immersing the base material, a step of immersing the base material in a second aqueous solution containing calcium ions and osteogenic ions, a step of heating the base material in the air, water, an aqueous acid solution, and an aqueous solution containing bone forming ions It comprises a step of immersing in a third aqueous solution comprising at least one selected from the group consisting of:
 第1の水溶液に浸けることにより、基材中のチタンと水溶液が反応して基材表面にチタン酸水素ナトリウムあるいはチタン酸水素カリウムの層が形成される。次いで第2の水溶液に浸けると、チタン酸水素ナトリウムあるいはチタン酸水素カリウム層中のナトリウムあるいはカリウムイオンが、水溶液中のカルシウムイオン及び骨形成イオンと交換される。交換されるカルシウムイオンと骨形成イオンの割合は、第2の水溶液におけるカルシウムイオンと骨形成イオンの濃度比を変えることで任意に制御できる。このような制御が可能になる理由は、第1の水溶液処理で形成されるチタン酸水素ナトリウムあるいはチタン酸水素カリウムが層状の構造を有することに起因する。このように異なる2種類の水溶液に段階的に浸けることにより、カルシウムイオン及び骨形成イオンを所望の割合で含み、両イオン濃度が表面から内部に向かって漸減する傾斜組成のチタン酸塩層が基材上に形成される。 By soaking in the first aqueous solution, the titanium in the base material reacts with the aqueous solution to form a sodium hydrogen titanate or potassium hydrogen titanate layer on the surface of the base material. Then, when immersed in the second aqueous solution, sodium or potassium ions in the sodium hydrogen titanate or potassium hydrogen titanate layer are exchanged with calcium ions and bone forming ions in the aqueous solution. The ratio of calcium ions and osteogenic ions to be exchanged can be arbitrarily controlled by changing the concentration ratio of calcium ions and osteogenic ions in the second aqueous solution. The reason that such control is possible is that sodium hydrogen titanate or potassium hydrogen titanate formed by the first aqueous solution treatment has a layered structure. By gradually immersing in two different aqueous solutions in this way, a titanate layer having a gradient composition containing calcium ions and osteogenic ions in a desired ratio and gradually decreasing from the surface toward the inside is obtained. Formed on the material.
 これを大気中で加熱することにより、脱水して機械的及び化学的に安定な無水のチタン酸塩層となり、表面層の引っかき抵抗が著しく向上する。
 その後、水あるいは酸水溶液からなる第3の水溶液に浸けると、チタン酸塩層中のカルシウムイオン及び骨形成イオンの一部がヒドロニウムイオンに交換されて、表面がアパタイト形成能を発揮する程度に活性化される。また、第3の水溶液として骨形成イオンを含む水溶液を用いた場合、チタン酸塩層中の骨形成イオンが第3の水溶液に溶出することなくカルシウムイオンの一部がヒドロニウムイオンに交換されるので、チタン酸塩層中の骨形成イオン濃度を減少させることなくアパタイト形成能を発揮する程度に基材表面が活性化される。そのアパタイト形成能は、全表面にアパタイトを形成するのに3日で足りるという高いものであり、しかも多湿下で長期保存されても維持される。このチタン酸塩層に含まれる骨形成イオンは、生体内で徐々に溶出して骨形成を促進する。
By heating this in the air, it becomes dehydrated and becomes a mechanically and chemically stable anhydrous titanate layer, and the scratch resistance of the surface layer is remarkably improved.
Thereafter, when immersed in a third aqueous solution made of water or an acid aqueous solution, calcium ions and bone-forming ions in the titanate layer are partially exchanged for hydronium ions, and the surface exhibits an apatite-forming ability. Activated. When an aqueous solution containing osteogenic ions is used as the third aqueous solution, some of the calcium ions are exchanged for hydronium ions without eluting the osteogenic ions in the titanate layer into the third aqueous solution. Therefore, the substrate surface is activated to such an extent that it exhibits the ability to form apatite without reducing the bone-forming ion concentration in the titanate layer. The apatite-forming ability is as high as 3 days to form apatite on the entire surface, and is maintained even when stored for a long time under high humidity. Bone-forming ions contained in the titanate layer are gradually eluted in vivo to promote bone formation.
 以上のように、この発明によって得られる骨修復材料は、生体内に埋め込んだ場合、周囲の骨形成を促進し、速やかに生体骨と結合して骨欠損部を修復することができ、また、保存性に優れることから、手術用に常備しておくことができる。 As described above, when the bone repair material obtained by the present invention is embedded in a living body, it can promote the formation of surrounding bone, and can quickly bond to a living bone to repair a bone defect, Since it is excellent in preservability, it can be kept for surgery.
X線光電子分光分析(XPS)に基づく実施例1の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 1 based on X-ray photoelectron spectroscopy (XPS) is shown. XPSに基づく実施例2の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 2 based on XPS is shown. XPSに基づく実施例4の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 4 based on XPS is shown. XPSに基づく実施例5の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 5 based on XPS is shown. グロー放電発光分光分析(GD-OES)に基づく実施例7の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 7 based on glow discharge optical emission spectrometry (GD-OES) is shown. GD-OESに基づく実施例8の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 8 based on GD-OES is shown. GD-OESに基づく実施例9の試料の表面付近のイオン分布を示す。The ion distribution near the surface of the sample of Example 9 based on GD-OES is shown. 実施例の試料の薄膜X線回折パターンを示す。The thin film X-ray diffraction pattern of the sample of an Example is shown. 実施例1、4、7、8、9の試料からPBSへ溶出した骨形成イオンの誘導結合プラズマ発光分析(ICP)分析結果を示す。The inductively coupled plasma emission spectrometry (ICP) analysis result of the osteogenic ion eluted from the sample of Examples 1, 4, 7, 8, and 9 to PBS is shown. 実施例1、2の試料からPBSへ溶出した骨形成イオンのICP分析結果を示す。The ICP analysis result of the osteogenic ion eluted from the sample of Examples 1 and 2 into PBS is shown. 実施例4、5の試料からPBSへ溶出した骨形成イオンのICP分析結果を示す。The ICP analysis result of the osteogenic ion eluted from the samples of Examples 4 and 5 into PBS is shown.
 前記チタン酸塩層は、表面から0.1~10μmの深さの範囲において通常0.1~10原子%のカルシウムイオン濃度と0.1~5原子%の骨形成イオン濃度を有し、1~5原子%のカルシウムイオン濃度と0.1~5原子%の骨形成イオン濃度を有するのが好ましい。導入できるカルシウムイオン濃度及び骨形成イオン濃度は第2の水溶液のpHを上げることによりおよそ10原子%まで高めることができる。カルシウムイオン濃度が0.1原子%に満たない場合は、アパタイトを構成するカルシウム成分が表面に乏しすぎてアパタイトを形成しにくい。5原子%を超えると、表面層においてチタン酸カルシウムのように安定な化合物の割合が増すのでアパタイトを形成しにくい。骨形成イオンの体内における溶出量は、前記チタン酸塩層における骨形成イオン濃度に依存する。従って、骨形成イオン濃度が0.1原子%に満たない場合は、体内での溶出量が少なくなり十分な骨形成効果が得られない。ただし、5原子%を超えると、表面層が安定な化合物になるのでアパタイトを形成しにくい。 The titanate layer usually has a calcium ion concentration of 0.1 to 10 atomic% and an osteogenic ion concentration of 0.1 to 5 atomic% in a depth range of 0.1 to 10 μm from the surface. Preferably it has a calcium ion concentration of -5 atomic% and an osteogenic ion concentration of 0.1-5 atomic%. The calcium ion concentration and osteogenic ion concentration that can be introduced can be increased to about 10 atomic% by raising the pH of the second aqueous solution. When the calcium ion concentration is less than 0.1 atomic%, the calcium component constituting the apatite is too scarce on the surface, and it is difficult to form apatite. If it exceeds 5 atomic%, the ratio of a stable compound such as calcium titanate in the surface layer increases, so that it is difficult to form apatite. The amount of bone-forming ions eluted in the body depends on the bone-forming ion concentration in the titanate layer. Therefore, when the bone-forming ion concentration is less than 0.1 atomic%, the amount of elution in the body is reduced and a sufficient bone-forming effect cannot be obtained. However, if it exceeds 5 atomic%, the surface layer becomes a stable compound, so it is difficult to form apatite.
 第2の水溶液におけるカルシウムイオンの濃度は通常0.01~5000mMの範囲であり、好ましくは0.01~100mMである。骨形成イオンの濃度は通常0.01~5000mMの範囲であり、好ましくは0.01~100mMの範囲である。いずれも下限に満たない場合、前記チタン酸塩層に前記の好ましい濃度でカルシウムイオン及び骨形成イオンを導入することが極めて困難となる。上限を越える場合、アパタイト形成に不利な安定な化合物を表面に形成しやすくなる。 The concentration of calcium ions in the second aqueous solution is usually in the range of 0.01 to 5000 mM, preferably 0.01 to 100 mM. The concentration of osteogenic ions is usually in the range of 0.01 to 5000 mM, preferably in the range of 0.01 to 100 mM. When both are less than the lower limit, it becomes extremely difficult to introduce calcium ions and osteogenic ions into the titanate layer at the preferable concentration. When the upper limit is exceeded, a stable compound that is disadvantageous for apatite formation is easily formed on the surface.
 基材を浸漬するときの第2の水溶液の温度および浸漬時間は通常、それぞれ20℃以上、0.5時間以上であり、好ましくはそれぞれ40℃以上、24時間以上である。いずれも下限に満たない場合、前記チタン酸塩層に前記の好ましい濃度でカルシウムイオン及び骨形成イオンを導入することが極めて困難となる。
 基材を大気中で加熱するときの温度及び保持時間は通常、それぞれ400℃以上、0.5時間以上で、好ましくは600℃以上、1時間以上である。いずれも下限に満たない場合、前記チタン酸塩層のひっかき抵抗が乏しくなる。
The temperature and immersion time of the second aqueous solution when dipping the substrate are usually 20 ° C. or more and 0.5 hour or more, respectively, preferably 40 ° C. or more and 24 hours or more, respectively. When both are less than the lower limit, it becomes extremely difficult to introduce calcium ions and osteogenic ions into the titanate layer at the preferable concentration.
The temperature and holding time when heating the substrate in the atmosphere are usually 400 ° C. or more and 0.5 hour or more, respectively, preferably 600 ° C. or more and 1 hour or more. When both are less than the lower limit, the scratch resistance of the titanate layer becomes poor.
 第3の水溶液に酸及び骨形成イオンを含む水溶液を使用する場合の酸及び骨形成イオン濃度は通常、それぞれ0.001~100mMおよび1~1000mMであり、好ましくはそれぞれ0.01~100mM及び1~1000mMである。いずれも下限に満たない場合、水を用いた場合と同程度の効果しか得られず、上限を越える場合、アパタイト形成に不利な安定な化合物を表面に形成しやすくなる。骨形成イオン含有水溶液は通常、酸性、中性又は弱アルカリ性であり、pH=10以上のものは好ましくない。
 基材を浸漬するときの第3の水溶液の温度および浸漬時間は通常、それぞれ60℃以上、3時間以上であり、好ましくはそれぞれ80℃以上、24時間以上である。この第3の水溶液に酸溶液を使用した場合、水を使用した場合よりも短時間で活性化される。酸水溶液に含まれる好ましい酸は、塩酸、硝酸、酢酸及び硫酸から選択される1つ以上である。これらの酸は、取り扱いが容易であるし、基材を浸食することもないからである。浸漬温度及び浸漬時間が下限に満たない場合、十分に活性化されない。
 第2及び第3の水溶液における骨形成イオンの濃度を変えることにより、前記チタン酸塩層における濃度を変えることが出来る。
When an aqueous solution containing acid and osteogenic ions is used in the third aqueous solution, the acid and osteogenic ion concentrations are usually 0.001 to 100 mM and 1 to 1000 mM, respectively, preferably 0.01 to 100 mM and 1 respectively. ~ 1000 mM. When both are less than the lower limit, only the same effect as when water is used is obtained, and when the upper limit is exceeded, a stable compound that is disadvantageous for apatite formation is easily formed on the surface. The aqueous solution containing osteogenic ions is usually acidic, neutral or weakly alkaline, and those having pH = 10 or more are not preferred.
The temperature and immersion time of the third aqueous solution when dipping the substrate are usually 60 ° C. or more and 3 hours or more, respectively, preferably 80 ° C. or more and 24 hours or more, respectively. When an acid solution is used for the third aqueous solution, activation is performed in a shorter time than when water is used. The preferred acid contained in the acid aqueous solution is one or more selected from hydrochloric acid, nitric acid, acetic acid and sulfuric acid. This is because these acids are easy to handle and do not erode the substrate. When the immersion temperature and the immersion time are less than the lower limit, they are not sufficiently activated.
By changing the concentration of osteogenic ions in the second and third aqueous solutions, the concentration in the titanate layer can be changed.
-実施例1-
 10mm×10mm×1mmの大きさの純チタン金属板を#400のダイヤモンドパッドを用いて研磨し、アセトン、2-プロパノール、超純水で各30分間超音波洗浄した後、5Mの水酸化ナトリウム水溶液5mlに60℃で24時間浸漬し(以下、「アルカリ処理」という)、超純水で30秒間洗浄した。このチタン金属板を塩化カルシウムと塩化ストロンチウムの濃度がいずれも50mMになるように混合した水溶液10mlに40℃で24時間浸漬した。(以下、「カルシウム/ストロンチウム処理」という。)次いで、チタン金属板を電気炉中で常温から600℃まで5℃/minの速度で昇温し、大気中600℃で1時間保持して、炉内で放冷した(以下、「加熱処理」という。)。その後、80℃の温水に24時間浸漬し(以下、「温水処理」という)、超純水により30秒間洗浄した。
-Example 1-
A pure titanium metal plate with a size of 10 mm × 10 mm × 1 mm is polished with a # 400 diamond pad, ultrasonically washed with acetone, 2-propanol, and ultrapure water for 30 minutes each, and then 5M aqueous sodium hydroxide solution It was immersed in 5 ml at 60 ° C. for 24 hours (hereinafter referred to as “alkali treatment”) and washed with ultrapure water for 30 seconds. This titanium metal plate was immersed in 10 ml of an aqueous solution mixed so that the concentrations of calcium chloride and strontium chloride were both 50 mM at 40 ° C. for 24 hours. (Hereinafter referred to as “calcium / strontium treatment”.) Next, the titanium metal plate was heated from normal temperature to 600 ° C. at a rate of 5 ° C./min in an electric furnace and held at 600 ° C. for 1 hour in the atmosphere. The inside was allowed to cool (hereinafter referred to as “heat treatment”). Then, it was immersed in warm water at 80 ° C. for 24 hours (hereinafter referred to as “warm water treatment”) and washed with ultrapure water for 30 seconds.
-実施例2-
 実施例1において、温水処理の代わりに1Mの塩化ストロンチウムに80℃で24時間浸漬した(以下、「ストロンチウム処理」という。)ことを除く他は実施例1と同じ条件で試料を製造した。
-Example 2-
In Example 1, a sample was produced under the same conditions as in Example 1 except that the sample was immersed in 1M strontium chloride at 80 ° C. for 24 hours instead of hot water treatment (hereinafter referred to as “strontium treatment”).
-実施例3-
 実施例1のカルシウム/ストロンチウム処理において、塩化カルシウムと塩化ストロンチウムの濃度がそれぞれ80mMと20mMになるように混合した水溶液10mlに40℃で24時間浸漬したことを除く他は実施例1と同じ条件で試料を製造した。
-Example 3-
In the calcium / strontium treatment of Example 1, the same conditions as in Example 1 except that it was immersed in 10 ml of an aqueous solution mixed so that the concentrations of calcium chloride and strontium chloride were 80 mM and 20 mM, respectively, at 40 ° C. for 24 hours. Samples were manufactured.
-実施例4-
 実施例1において、カルシウム/ストロンチウム処理の代わりに塩化カルシウムと塩化マグネシウムの濃度がそれぞれ40mMと60mMになるように混合した水溶液10mlに40℃で24時間浸漬した(以下、「カルシウム/マグネシウム処理」という。)ことを除く他は実施例1と同じ条件で試料を製造した。
-Example 4-
In Example 1, instead of the calcium / strontium treatment, it was immersed in 10 ml of an aqueous solution mixed so that the concentrations of calcium chloride and magnesium chloride were 40 mM and 60 mM, respectively, at 40 ° C. for 24 hours (hereinafter referred to as “calcium / magnesium treatment”). A sample was produced under the same conditions as in Example 1 except that.
-実施例5-
 実施例4において、温水処理の代わりに1Mの塩化マグネシウム水溶液に80℃で24時間浸漬した(以下、「マグネシウム処理」という。)ことを除く他は実施例4と同じ条件で試料を製造した。
-Example 5
In Example 4, a sample was produced under the same conditions as in Example 4 except that it was immersed in a 1 M aqueous magnesium chloride solution at 80 ° C. for 24 hours (hereinafter referred to as “magnesium treatment”) instead of hot water treatment.
-実施例6-
 実施例4のカルシウム/マグネシウム処理において、塩化カルシウムと塩化マグネシウムの濃度がそれぞれ2Mと3Mになるように混合した水溶液10mlに40℃で24時間浸漬し、温水処理の代わりにマグネシウム処理したことを除く他は実施例4と同じ条件で試料を製造した。
-Example 6-
In the calcium / magnesium treatment of Example 4, it was immersed in 10 ml of an aqueous solution mixed so that the concentrations of calcium chloride and magnesium chloride were 2M and 3M, respectively, at 40 ° C. for 24 hours, except that it was treated with magnesium instead of hot water treatment. Other than that, a sample was manufactured under the same conditions as in Example 4.
-実施例7-
 実施例1において、カルシウム/ストロンチウム処理の代わりに酢酸カルシウムと酢酸亜鉛の濃度がそれぞれ99.99mMと0.01mMになるように混合した水溶液10 mlに40℃で24時間浸漬し(以下、「カルシウム/亜鉛処理」という。)、温水処理の代わりに1mMの酢酸に80℃で24時間浸漬した(以下、「酢酸処理」という。)ことを除く他は実施例1と同じ条件で試料を製造した。
-Example 7-
In Example 1, instead of the calcium / strontium treatment, the sample was immersed in 10 ml of an aqueous solution mixed so that the concentrations of calcium acetate and zinc acetate were 99.99 mM and 0.01 mM, respectively, at 40 ° C. for 24 hours (hereinafter referred to as “calcium”). The sample was produced under the same conditions as in Example 1 except that it was immersed in 1 mM acetic acid at 80 ° C. for 24 hours (hereinafter referred to as “acetic acid treatment”) instead of hot water treatment. .
-実施例8-
 実施例1において、カルシウム/ストロンチウム処理の代わりに塩化カルシウムと塩化リチウムの濃度がそれぞれ0.01mMと99.99mMになるように混合した水溶液10mlに40℃で24時間浸漬し(以下、「カルシウム/リチウム処理」という。)、温水処理の代わりに1Mの塩化リチウム水溶液に80℃で24時間浸漬した(以下、「リチウム処理」という)ことを除く他は実施例1と同じ条件で試料を製造した。
-Example 8-
In Example 1, instead of calcium / strontium treatment, the sample was immersed in 10 ml of an aqueous solution mixed so that the concentrations of calcium chloride and lithium chloride were 0.01 mM and 99.99 mM at 40 ° C. for 24 hours (hereinafter referred to as “calcium / strontium”). A sample was prepared under the same conditions as in Example 1 except that it was immersed in a 1M aqueous lithium chloride solution at 80 ° C. for 24 hours (hereinafter referred to as “lithium treatment”) instead of hot water treatment. .
-実施例9-
 実施例1において、カルシウム/ストロンチウム処理の代わりに塩化カルシウムと塩化ガリウムの濃度がそれぞれ99.95mMと0.05mMになるように混合した水溶液10mlに40℃で24時間浸漬した(以下、「カルシウム/ガリウム処理」という。)ことを除く他は実施例1と同じ条件で試料を製造した。
-Example 9-
In Example 1, instead of the calcium / strontium treatment, it was immersed in 40 ml of an aqueous solution mixed so that the concentrations of calcium chloride and gallium chloride were 99.95 mM and 0.05 mM, respectively (hereinafter referred to as “calcium / strontium”). A sample was manufactured under the same conditions as in Example 1 except that it was referred to as “gallium treatment”.
-比較例1-
 実施例1において、温水処理を行わなかった他は実施例1と同じ条件で試料を製造した。
-比較例2-
 実施例1において、加熱処理における保持温度を200℃にし、温水処理を行わなかった他は実施例1と同じ条件で試料を製造した。
-比較例3-
 実施例1において、加熱処理及び温水処理を行わなかった他は実施例1と同じ条件で試料を製造した。
-Comparative Example 1-
In Example 1, a sample was produced under the same conditions as in Example 1 except that the hot water treatment was not performed.
-Comparative Example 2-
In Example 1, a sample was manufactured under the same conditions as in Example 1 except that the holding temperature in the heat treatment was set to 200 ° C. and the hot water treatment was not performed.
-Comparative Example 3-
In Example 1, a sample was produced under the same conditions as in Example 1 except that the heat treatment and the hot water treatment were not performed.
 以上の実施例及び比較例の試料の製造条件をまとめて表1に記載する。
Figure JPOXMLDOC01-appb-T000001
The production conditions of the samples of the above examples and comparative examples are summarized in Table 1.
Figure JPOXMLDOC01-appb-T000001
[組成分析]
 実施例及び比較例の試料表面の組成を加速電圧9kVでエネルギー分散X線分析法により分析し、あるいは1Mの塩酸に80℃で24時間浸漬することで溶出したカルシウムイオン及びリチウムイオンをICPにより分析した。その結果、各試料とも製造途中におけるアルカリ処理直後にはナトリウムが5.5原子%検出されたが、表2に示すようにカルシウム/ストロンチウム、カルシウム/マグネシウム、カルシウム/亜鉛、カルシウム/リチウム、カルシウム/ガリウム処理を施した試料ではナトリウムが消失し、代わりに1.5~3.3原子%のカルシウムと0.4~1.7原子%のストロンチウム、マグネシウム、亜鉛、ガリウムが検出され、あるいは0.27ppmのカルシウムイオンと0.19ppmのリチウムイオンが検出された。表1及び表2に示されるように、第2の水溶液に含まれるカルシウムイオン及び骨形成イオンの濃度比を変えることにより、また第3の水溶液に含まれる骨形成イオンの濃度を変えることにより、導入されるカルシウムイオン及び骨形成イオンの割合を任意に制御することができた。
[Composition analysis]
The composition of the sample surface of the example and the comparative example was analyzed by an energy dispersive X-ray analysis method at an acceleration voltage of 9 kV, or the calcium ion and the lithium ion eluted by being immersed in 1 M hydrochloric acid at 80 ° C. for 24 hours were analyzed by ICP. did. As a result, in each sample, 5.5 atomic% of sodium was detected immediately after the alkali treatment in the course of production, but as shown in Table 2, calcium / strontium, calcium / magnesium, calcium / zinc, calcium / lithium, calcium / In the gallium-treated sample, sodium disappears, and instead 1.5 to 3.3 atomic% calcium and 0.4 to 1.7 atomic% strontium, magnesium, zinc, gallium are detected, or 0. 27 ppm of calcium ions and 0.19 ppm of lithium ions were detected. As shown in Tables 1 and 2, by changing the concentration ratio of calcium ions and osteogenic ions contained in the second aqueous solution, and by changing the concentration of osteogenic ions contained in the third aqueous solution, It was possible to arbitrarily control the ratio of calcium ions and osteogenic ions introduced.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 実施例1、2、4及び5のXPS及び実施例7~9のGD-OES結果によれば、図1~7に示すように表面より1μmの深さまでカルシウムイオンと共にストロンチウムイオン、マグネシウムイオン、亜鉛イオン、リチウムイオンまたはガリウムイオンが導入され、それらの濃度が深さと共に傾斜的に減少していることが認められた。
 表面試料の結晶構造を薄膜X線回折により調べると、図8に示すように実施例1、4、7-9の試料すべてに骨形成イオンを含むチタン酸カルシウムとルチル型及びアナターゼ型酸化チタンが形成されていることがわかった。
According to the XPS of Examples 1, 2, 4 and 5 and the GD-OES results of Examples 7 to 9, as shown in FIGS. 1 to 7, strontium ions, magnesium ions, zinc together with calcium ions to a depth of 1 μm from the surface. It was observed that ions, lithium ions or gallium ions were introduced and their concentrations decreased in a gradient with depth.
When the crystal structure of the surface sample is examined by thin film X-ray diffraction, as shown in FIG. 8, all of the samples of Examples 1, 4, and 7-9 contain calcium titanate containing bone-forming ions, rutile type, and anatase type titanium oxide. It was found that it was formed.
[ひっかき抵抗評価]
 実施例1-3の試料及び比較例1-3の試料のひっかき抵抗をスクラッチテスターにより測定したところ、表3に示すように200℃以下で加熱処理された試料のひっかき抵抗は10mN未満と低かったが、600℃で加熱処理された試料のひっかき抵抗は50mN以上と高かった。
[Evaluation of scratch resistance]
The scratch resistance of the sample of Example 1-3 and the sample of Comparative Example 1-3 was measured with a scratch tester. As shown in Table 3, the scratch resistance of the sample heat-treated at 200 ° C. or lower was as low as less than 10 mN. However, the scratch resistance of the sample heat-treated at 600 ° C. was as high as 50 mN or more.
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
[アパタイト形成能評価]
 実施例及び比較例の試料を36.5℃に保たれたISO規格23317の擬似体液(SBF)に浸漬したところ、表2及び表3に示すようにすべての実施例でSBF浸漬3日以内にアパタイトが表面全体すなわち全表面積の99%以上を覆うように析出した。したがって、これらの試料は生体内で高いアパタイト形成能を示すことが確かめられた。一方、加熱処理後、第3の水溶液処理を施さなかった比較例1の試料はSBF浸漬3日以内にアパタイトを形成しなかった。
[Apatite forming ability evaluation]
When the samples of Examples and Comparative Examples were immersed in a simulated body fluid (SBF) of ISO standard 23317 maintained at 36.5 ° C., as shown in Table 2 and Table 3, in all Examples, within 3 days of SBF immersion Apatite was deposited so as to cover the entire surface, ie 99% or more of the total surface area. Therefore, it was confirmed that these samples showed high apatite-forming ability in vivo. On the other hand, after the heat treatment, the sample of Comparative Example 1 that was not subjected to the third aqueous solution treatment did not form apatite within 3 days of SBF immersion.
[骨形成イオンの溶出性評価]
 実施例1-2、4-5、7-9の試料を36.5℃に保たれたリン酸緩衝液(PBS)に様々な時間浸漬し、各PBS中に溶出する骨形成イオンの濃度をICPにより測定した。その結果、図9に示すようにPBS中にそれぞれ、0.03~0.9ppmの骨形成イオンが徐々に溶出する様子が認められた。したがって、この試料は生体内で骨形成イオンを徐放することがわかった。特に第3の水溶液として骨形成イオンを含むものを用いた実施例2及び5の試料は、図10及び11に示すように温水を用いた実施例1及び4の試料に比べて浸漬開始時から骨形成イオンの溶出量が多かった。また、実施例7の試料から溶出した亜鉛イオン濃度は非特許文献5で骨形成に効果があったと報告されている濃度のおよそ倍の濃度であるので、高い骨形成効果が期待される。更に、表3に示すように、第2及び第3の水溶液におけるストロンチウムイオンの濃度を変えることにより、表面層におけるストロンチウムイオン濃度を変え、その結果、溶出するストロンチウムイオンの濃度を変えることが出来ることも確認できた。
[Evaluation of dissolution of bone-forming ions]
The samples of Examples 1-2, 4-5, and 7-9 were immersed in phosphate buffer (PBS) maintained at 36.5 ° C. for various times, and the concentration of osteogenic ions eluted in each PBS was determined. Measured by ICP. As a result, as shown in FIG. 9, it was observed that 0.03 to 0.9 ppm of osteogenic ions were gradually eluted in PBS. Therefore, this sample was found to release bone-forming ions in vivo. In particular, the samples of Examples 2 and 5 using the third aqueous solution containing bone-forming ions are compared to the samples of Examples 1 and 4 using warm water from the beginning of immersion as shown in FIGS. The amount of osteogenic ions eluted was large. Further, since the zinc ion concentration eluted from the sample of Example 7 is approximately twice the concentration reported in Non-Patent Document 5 as having an effect on bone formation, a high bone formation effect is expected. Furthermore, as shown in Table 3, by changing the concentration of strontium ions in the second and third aqueous solutions, the concentration of strontium ions in the surface layer can be changed, and as a result, the concentration of eluted strontium ions can be changed. Was also confirmed.

Claims (14)

  1.  チタン金属またはチタン合金からなる基材と、その基材表面にあってカルシウムイオン及び骨形成イオンを含むチタン酸塩層とを備え、10mN以上のひっかき抵抗を有することを特徴とする骨修復材料。 A bone repair material comprising: a base material made of titanium metal or a titanium alloy; and a titanate layer containing calcium ions and osteogenic ions on the surface of the base material, and having a scratch resistance of 10 mN or more.
  2.  前記骨形成イオンがストロンチウム、マグネシウム、亜鉛、リチウム及びガリウムのイオンから選択される1つ以上である請求項1に記載の骨修復材料。 The bone repair material according to claim 1, wherein the bone-forming ions are one or more selected from ions of strontium, magnesium, zinc, lithium and gallium.
  3.  前記チタン酸塩層におけるカルシウムイオン濃度が0.1~10原子%の範囲にあり、且つ骨形成イオン濃度が0.1~5原子%の範囲にある請求項1に記載の骨修復材料。 The bone repair material according to claim 1, wherein the calcium ion concentration in the titanate layer is in the range of 0.1 to 10 atomic% and the bone forming ion concentration is in the range of 0.1 to 5 atomic%.
  4.  前記チタン酸塩層が0.1~10μmの厚さを有する請求項1に記載の骨修復材料。 The bone repair material according to claim 1, wherein the titanate layer has a thickness of 0.1 to 10 µm.
  5.  36.5℃に保たれたISO規格23317の擬似体液に浸漬された後3日間以内に全表面積の99%以上の表面がアパタイトで被覆される請求項1に記載の骨修復材料。 The bone repair material according to claim 1, wherein a surface of 99% or more of the total surface area is coated with apatite within 3 days after being immersed in a simulated body fluid of ISO standard 23317 maintained at 36.5 ° C.
  6.  カルシウムイオン及び骨形成イオンを含まずナトリウムイオン及びカリウムイオンのうち1つ以上の陽イオンを含むアルカリ性の第1の水溶液に、チタンまたはチタン合金からなる基材を浸漬する工程と、カルシウムイオン及び骨形成イオンを含む第2の水溶液に基材を浸漬する工程と、基材を大気中で加熱する工程と、水、酸水溶液及び骨形成イオン含有水溶液から選ばれる一種以上からなる第3の水溶液に浸漬する工程を備えることを特徴とする骨修復材料の製造方法。 A step of immersing a base material made of titanium or a titanium alloy in an alkaline first aqueous solution not containing calcium ions and osteogenic ions but containing one or more cations of sodium ions and potassium ions; and calcium ions and bones A step of immersing the substrate in a second aqueous solution containing forming ions, a step of heating the substrate in the atmosphere, and a third aqueous solution comprising at least one selected from water, an aqueous acid solution and an aqueous solution containing bone forming ions The manufacturing method of the bone repair material characterized by including the process to immerse.
  7.  第2及び第3の水溶液に含まれる骨形成イオンが、ストロンチウム、マグネシウム、亜鉛、リチウム及びガリウムのイオンから選択される1つ以上である請求項6に記載の製造方法。 The method according to claim 6, wherein the bone forming ions contained in the second and third aqueous solutions are one or more selected from ions of strontium, magnesium, zinc, lithium and gallium.
  8.  第2の水溶液におけるカルシウムイオン濃度が0.01~5000mMの範囲にあり、骨形成イオンの濃度が0.01~5000mMの範囲にある請求項6に記載の製造方法。 The production method according to claim 6, wherein the calcium ion concentration in the second aqueous solution is in the range of 0.01 to 5000 mM and the concentration of osteogenic ions is in the range of 0.01 to 5000 mM.
  9.  第2の水溶液の温度が20℃以上であり、基材を第2の水溶液に浸漬する時間が0.5時間以上である請求項6に記載の製造方法。 The method according to claim 6, wherein the temperature of the second aqueous solution is 20 ° C or higher, and the time for immersing the substrate in the second aqueous solution is 0.5 hours or longer.
  10.  前記加熱処理の温度が400℃以上であり、保持時間が0.5時間以上である請求項6に記載の製造方法。 The manufacturing method according to claim 6, wherein the temperature of the heat treatment is 400 ° C or higher and the holding time is 0.5 hours or longer.
  11.  第3の水溶液が骨形成イオン含有水溶液であって、その骨形成イオンの濃度が1~1000mMの範囲にある請求項6に記載の製造方法。 The production method according to claim 6, wherein the third aqueous solution is an aqueous solution containing osteogenic ions, and the concentration of the osteogenic ions is in the range of 1 to 1000 mM.
  12.  第3の水溶液が酸水溶液であって、その酸水溶液に含まれる酸が塩酸、硝酸、酢酸及び硫酸から選択される1つ以上である請求項6に記載の製造方法。 The method according to claim 6, wherein the third aqueous solution is an acid aqueous solution, and the acid contained in the acid aqueous solution is one or more selected from hydrochloric acid, nitric acid, acetic acid, and sulfuric acid.
  13.  前記酸水溶液における酸の濃度が0.001~100mMの範囲にある請求項12に記載の製造方法。 The method according to claim 12, wherein the acid concentration in the acid aqueous solution is in the range of 0.001 to 100 mM.
  14.  第3の水溶液の温度が60℃以上であり、基材を第3の水溶液に浸漬する時間が3時間以上である請求項6に記載の製造方法。 The method according to claim 6, wherein the temperature of the third aqueous solution is 60 ° C or higher, and the time for immersing the substrate in the third aqueous solution is 3 hours or longer.
PCT/JP2013/071596 2012-08-16 2013-08-09 Bone repair material and production method therefor WO2014027612A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014530537A JP6206880B2 (en) 2012-08-16 2013-08-09 Bone repair material and manufacturing method thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012-180434 2012-08-16
JP2012180434 2012-08-16

Publications (1)

Publication Number Publication Date
WO2014027612A1 true WO2014027612A1 (en) 2014-02-20

Family

ID=50685576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/071596 WO2014027612A1 (en) 2012-08-16 2013-08-09 Bone repair material and production method therefor

Country Status (2)

Country Link
JP (2) JP6206880B2 (en)
WO (1) WO2014027612A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013100A1 (en) * 1993-11-09 1995-05-18 The Foundation For The Promotion Of Ion Engineering Bone substitute material and process for producing the same
JP2000093498A (en) * 1998-09-22 2000-04-04 Kobe Steel Ltd Bone substitution material and its production
JP2002102330A (en) * 2000-07-27 2002-04-09 Ion Kogaku Shinko Zaidan Bioimplant material and method of manufacturing the same
JP2006075500A (en) * 2004-09-13 2006-03-23 Pentax Corp Bioactive material and manufacturing method thereof
WO2009147819A1 (en) * 2008-06-03 2009-12-10 学校法人中部大学 Bone-repairing material and method for producing the same
JP2010533012A (en) * 2007-07-09 2010-10-21 アストラ・テック・アクチエボラーグ Bone tissue implants containing strontium ions
JP2010533011A (en) * 2007-07-09 2010-10-21 アストラ・テック・アクチエボラーグ Bone tissue implants containing lithium ions
JP2011032223A (en) * 2009-08-03 2011-02-17 Kanagawa Dental College Treating liquid of implant for living body, and method of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009024778A2 (en) * 2007-08-20 2009-02-26 Smith & Nephew Plc Bioactive material
EP2228079A1 (en) * 2009-03-03 2010-09-15 Graftys Gallium-doped phosphocalcic compounds
EP2228080A1 (en) * 2009-03-03 2010-09-15 Graftys Galliated calcium phosphate biomaterials

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013100A1 (en) * 1993-11-09 1995-05-18 The Foundation For The Promotion Of Ion Engineering Bone substitute material and process for producing the same
JP2000093498A (en) * 1998-09-22 2000-04-04 Kobe Steel Ltd Bone substitution material and its production
JP2002102330A (en) * 2000-07-27 2002-04-09 Ion Kogaku Shinko Zaidan Bioimplant material and method of manufacturing the same
JP2006075500A (en) * 2004-09-13 2006-03-23 Pentax Corp Bioactive material and manufacturing method thereof
JP2010533012A (en) * 2007-07-09 2010-10-21 アストラ・テック・アクチエボラーグ Bone tissue implants containing strontium ions
JP2010533011A (en) * 2007-07-09 2010-10-21 アストラ・テック・アクチエボラーグ Bone tissue implants containing lithium ions
WO2009147819A1 (en) * 2008-06-03 2009-12-10 学校法人中部大学 Bone-repairing material and method for producing the same
JP2011032223A (en) * 2009-08-03 2011-02-17 Kanagawa Dental College Treating liquid of implant for living body, and method of treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SEIJI YAMAGUCHI ET AL.: "23. Shudai 3 Kokyodo Teidansei Seitai Kassei Titanium-kei Zairyo no Chosei", DAI 30 KAI ANNUAL MEETING OF THE RESEARCH SOCIETY FOR ORTHOPAEDIC BIOMATERIALS PROGRAM - SHOROKUSHU, 30 November 2010 (2010-11-30), pages 44 *
SEIJI YAMAGUCHI ET AL.: "Symposium 1 Kanren 01 Strontium Ion o Joho suru Seitai Kassei Titanium Kinzoku", DAI 32 KAI ANNUAL MEETING OF THE RESEARCH SOCIETY FOR ORTHOPAEDIC BIOMATERIALS PROGRAM - SHOROKUSHU, 17 December 2012 (2012-12-17), pages 19 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
US11058799B2 (en) 2017-03-28 2021-07-13 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same
US11141505B2 (en) 2017-03-28 2021-10-12 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US11793907B2 (en) 2017-03-28 2023-10-24 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US11793910B2 (en) 2017-03-28 2023-10-24 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same

Also Published As

Publication number Publication date
JP6206880B2 (en) 2017-10-04
JP2017144342A (en) 2017-08-24
JP6358765B2 (en) 2018-07-18
JPWO2014027612A1 (en) 2016-07-25

Similar Documents

Publication Publication Date Title
Chu et al. Surface structure and properties of biomedical NiTi shape memory alloy after Fenton’s oxidation
JP5499347B2 (en) Bone repair material and manufacturing method thereof
WO1995013100A1 (en) Bone substitute material and process for producing the same
Hu et al. Corrosion products and mechanism on NiTi shape memory alloy in physiological environment
Sepahvandi et al. Photoluminescence in the characterization and early detection of biomimetic bone-like apatite formation on the surface of alkaline-treated titanium implant: State of the art
JP3461818B2 (en) Hard tissue repair material and method for producing the same
López et al. In vitro bioactivity assessment of metallic magnesium
Li et al. Structure, composition and morphology of bioactive titanate layer on porous titanium surfaces
JP6358765B2 (en) Bone repair material and manufacturing method thereof
Silva et al. Modification of surfaces of alumina-zirconia porous ceramics with Sr 2+ after SBF
Yamaguchi et al. Bioactive Ti metal with Ca-enriched surface layer able to release Zn ion
US8784864B2 (en) Bone repair material and method for producing the same
JP2003235954A (en) Bone conductive biomaterial and manufacturing method therefor
JP2000093498A (en) Bone substitution material and its production
Montinaro et al. Spark plasma sintered CaO-rich bioglass-derived glass-ceramics with different crystallinity ratios: A detailed investigation of their behaviour during biological tests in SBF
JP7016464B2 (en) Iodine-supported bone repair material and its manufacturing method
JP4625943B2 (en) Bone substitute material and manufacturing method thereof
JP7313612B2 (en) Medical implant made of high-purity magnesium and manufacturing method thereof
Chu et al. Biomimetic deposition process of an apatite coating on NiTi shape memory alloy
JP6783465B2 (en) Medical bioabsorbable member and its manufacturing method
JP2013236700A (en) Antibacterial bone repair material and method of manufacturing the same
WO2021049494A1 (en) Biocompatible implant and preparation method of biocompatible implant
JPH09238965A (en) Bone repair material and bone repair material with apatite film and manufacture thereof
Demircioğlu et al. Fabrication and mechanical behavior of calcium-phosphate in situ coating on Ti6Al4V substrates
Sun et al. Chemical stability of the titania layer formed synthetically on NiTi shape memory alloy as a barrier to prevent nickel ion release

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13848115

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014530537

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13848115

Country of ref document: EP

Kind code of ref document: A1